+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Bioinformatics Market Analysis, 2021

  • PDF Icon

    Report

  • 167 Pages
  • February 2021
  • Region: Asia Pacific
  • MarkNtel Advisors LLP
  • ID: 5439533

Market Overview


Bioinformatics is a sub-discipline of biology and computer science that involves both hardware and software to obtain, store, and interpret large quantities of biological data.

Market Segmentation


Cheminformatics Exhibits Fastest Growth


Based on Application, Cheminformatics is likely to grow in the Asia-Pacific Bioinformatics market during the forecast period. Cheminformatics tools are used primarily for managing high-throughput screening (HTS) and compound chemistry data. The advent of cheminformatics technologies allows drug discovery companies to save & reduce time & money by as much as 50%. The growing popularity of small molecule libraries is further expected to propel the growth of the Asia-Pacific Bioinformatics market in the coming years, reveals the author in their research report, “Asia-Pacific Bioinformatics Market Analysis, 2021.”

Market Opportunities


According to the publishers’ research report, “Asia-Pacific Bioinformatics Market Analysis, 2021,” the market is likely to grow at a CAGR of 17% during 2021-26 due to the increasing demand for cost-effective & analytical tools required in pharmacogenomics & proteomics. Moreover, the surging popularity of combinatorial chemistry techniques and the paradigm shift of consumers toward proteomics to enhance efforts to discover disease biomarkers & identify therapeutic targets also drive the demand for bioinformatics. Besides, soaring government funding to R&D, surging mergers & acquisitions to accelerate innovation, and the growing reliance of pharmaceutical companies on bioinformatics are other crucial factors likely to propel the overall market growth in the forecast period.

Competitive Landscape


According to the publishers’, the key players with a considerable market share in the Asia-Pacific Bioinformatics market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Affymetrix, Applied Biological Materials Inc., Illumina, Inc., QIAGEN, Biomax Biotechnics, DNANEXUS, Water corporation, Genebio, Integromics, Inc., PerkinElmer Inc., Partek, BGI, Dassault systems, etc.

Key Questions Answered in the Market Research Report:


1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Asia-Pacific Bioinformatics Market?
2. What is the country-wise industry size, growth drivers, and challenges key market trends?
3. What are the key innovations, opportunities, current, and future trends, and regulations in the Asia-Pacific Bioinformatics Market?
4. Who are the key competitors, what are their key strengths and weakness, and how they perform in Asia-Pacific Bioinformatics Market based on the competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of the Asia-Pacific Bioinformatics Market study?

Table of Contents

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation
2. Preface3. Executive Summary4. Impact of COVID-19 on Asia-Pacific Bioinformatics Market
5. Asia-Pacific Bioinformatics Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Product & Services
5.2.1.1. Platforms
5.2.1.1.1. Sequence Analysis Platforms
5.2.1.1.2. Sequence Alignment Platforms
5.2.1.1.3. Structural & Functional Analysis Platforms
5.2.1.1.4. Sequence Manipulation Platforms
5.2.1.1.5. Other
5.2.1.2. Knowledge Management Tools
5.2.1.2.1. Generalized Knowledge Management Tools
5.2.1.2.2. Specialized Knowledge Management Tools
5.2.1.3. Services
5.2.1.3.1. Data Analysis Services
5.2.1.3.2. Database Management Services
5.2.1.3.3. Other
5.2.2. By Application
5.2.2.1. Genomics
5.2.2.2. Metabolomics
5.2.2.3. Chemoinformatics & Drug Design
5.2.2.4. Transcriptomics
5.2.2.5. Proteomics
5.2.2.6. Other (Molecular Medicine, Preventive Medicine, etc.)
5.2.3. By Type of Sector
5.2.3.1. Animal Biotechnology
5.2.3.2. Environmental Biotechnology
5.2.3.2.1. Waste Clean-up/ Bioremediation
5.2.3.2.2. Alternative Energy Sources
5.2.3.3. Agriculture Biotechnology
5.2.3.3.1. Nutritional Quality Improvement
5.2.3.3.2. Biodiversity Informatics
5.2.3.3.3. Improvement of Plant Resistance
5.2.3.3.4. Pest Resistance
5.2.3.3.5. Crop Yield Improvement
5.2.3.4. Forensic Biotechnology
5.2.3.5. Medical Biotechnology
5.2.3.5.1. Reproductive Biotechnology
5.2.3.5.2. Gene Therapy
5.2.3.5.3. Molecular Medicine
5.2.3.5.4. Clinical Diagnostics
5.2.3.5.5. Drug Development
5.2.3.6. Academics
5.2.3.7. Others
5.2.4. By Country
5.2.4.1. China
5.2.4.2. India
5.2.4.3. Japan
5.2.4.4. Australia
5.2.4.5. South Korea
5.2.4.6. Taiwan
5.2.4.7. Southeast Asia
5.2.4.8. Others
5.2.5. By Competitors
5.2.5.1. Competition Characteristics
5.2.5.2. Market Share & Analysis
5.2.5.3. Competitive Metrix
6. China Bioinformatics Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Product & Services
6.2.2. By Application
6.2.3. By Type of Sector
7. India Bioinformatics Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Product & Services
7.2.2. By Application
7.2.3. By Type of Sector
8. Japan Bioinformatics Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Product & Services
8.2.2. By Application
8.2.3. By Type of Sector
8.2.4. Australia Bioinformatics Market Outlook, 2016-2026F
8.3. Market Size & Analysis
8.3.1. By Revenues
8.4. Market Share & Analysis
8.4.1. By Product & Services
8.4.2. By Application
8.4.3. By Type of Sector
8.4.4. South Korea Bioinformatics Market Outlook, 2016-2026F
8.5. Market Size & Analysis
8.5.1. By Revenues
8.6. Market Share & Analysis
8.6.1. By Product & Services
8.6.2. By Application
8.6.3. By Type of Sector
9. Taiwan Bioinformatics Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Product & Services
9.2.2. By Application
9.2.3. By Type of Sector
10. Southeast Asia Bioinformatics Market Outlook, 2016-2026F
10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Product & Services
10.2.2. By Application
10.2.3. By Type of Sector
11. Asia-Pacific Bioinformatics Market Trends & Insights
12. Asia-Pacific Bioinformatics Market Dynamics
12.1. Drivers
12.2. Challenges
12.3. Impact Analysis
13. Asia-Pacific Bioinformatics Market Hotspots & Opportunities14. Asia-Pacific Bioinformatics Market Regulations & Policy15. Key Strategic Imperatives for Success and Growth
16. Competition Outlook
16.1. Competition Matrix
16.1.1. Target Product/ Services
16.1.2. Target Markets
16.1.3. Target End Users
16.1.4. Research & Development
16.1.5. Strategic Alliances
16.1.6. Strategic Initiatives
16.2. Company Profile
16.2.1. Thermo Fisher Scientific
16.2.2. Eurofins Scientific
16.2.3. Illumina
16.2.4. Perkinelmer, Inc.
16.2.5. Qiagen Bioinformatics
16.2.6. Agilent Technologies
16.2.7. Dnastar
16.2.8. Waters Corporation
16.2.9. Sophia Genetics
16.2.10. Partek
16.2.11. Biomax Informatics AG
16.2.12. Wuxi Nextcode
16.2.13. Beijing Genomics Institute (BGI)
17. Disclaimer

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Affymetrix
  • Applied Biological Materials Inc.
  • Illumina Inc.
  • QIAGEN
  • Biomax Biotechnics
  • DNANEXUS
  • Water corporation
  • Genebio
  • Integromics Inc.
  • PerkinElmer Inc.
  • Partek
  • BGI
  • Dassault systems

Methodology

Loading
LOADING...